EUVIMEDEUVIMED entdecken
Crossref

Long noncoding RNA LINC00675 drives malignancy in acute myeloid leukemia via the miR-6809 -CDK6 axis

Xinyi Long, Huinan Jiang, Zhuogang Liu, Jing Liu, Rong Hu

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Xinyi Long und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110000, China; Department of Hematology, The Third Xiangya Hospita…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 6, Leukemia, Myeloid, Acute, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematological malignancies such as acute myeloid leukemia (AML) have a low cure rate and a high recurrence rate. Long noncoding RNAs (LNCs) are essential regulators of tumorigenesis and progression. The role of lncRNA LINC00675 in AML has rarely been reported. This study revealed elevated LINC00675 expression in AML that promotes proliferation and inhibits apoptosis. Mechanistically, LINC00675 combines with miR-6809 to promote the expression of CDK6 in vitro and in vivo. Immune-checkpoint genes were expressed more highly in LINC00675-high patients. A high level of LINC00675 expression may make patients more susceptible to palbociclib treatments. In conclusion, our study demonstrated that LINC00675 is an oncogenic lncRNA that enhances the malignancy of AML by upregulating CDK6 expression through miR-6809 sponging, providing a new perspective and feasible target for the diagnosis and treatment of AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 6Leukemia, Myeloid, AcuteMicroRNAsRNA, Long NoncodingHumansApoptosisCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

Acute myeloid leukemiaCDK6LINC00675LncRNAMiR-6809

Substanzen

CDK6 protein, humanCyclin-Dependent Kinase 6MicroRNAsRNA, Long NoncodingMIRN6809 microRNA, humanlong non-coding RNA Linc00675, human

Autor:innen und Institutionen

  • Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110000, China; Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110000, China.
  • Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110000, China. Electronic address: hur@sj-hospital.org.

Zitieren

APA

Long, X., Jiang, H., Liu, Z., Liu, J., & Hu, R. (2024). Long noncoding RNA LINC00675 drives malignancy in acute myeloid leukemia via the miR-6809 -CDK6 axis. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155221

Vancouver

Long X, Jiang H, Liu Z, Liu J, Hu R. Long noncoding RNA LINC00675 drives malignancy in acute myeloid leukemia via the miR-6809 -CDK6 axis. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155221

BibTeX
@article{Long2024,
  author = {Long, Xinyi and Jiang, Huinan and Liu, Zhuogang and Liu, Jing and Hu, Rong},
  title = {Long noncoding RNA LINC00675 drives malignancy in acute myeloid leukemia via the miR-6809 -CDK6 axis},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155221}
}
Kostenlos starten →